Helius is a New Zealand-owned biotechnology company focused on medicinal cannabis research and development. The country’s largest licensed producer and the first medicinal cannabis cultivator to be certified as New Zealand Grown through Buy NZ Made Campaign, Helius a leader in this nascent market. The company operates a state-of-the-art GMP facility in Auckland with indoor controlled growing systems, integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations. Following changes in New Zealand’s regulatory environment, Helius is poised to set the standard for effective and accessible medicinal cannabis products.

Biotechnology

Helius Therapeutics

Paul Manning

Lohsing Cheng

Lee Smith

Anita Biggelaar

Abbey Rutz

Mary Alice Simon

Gavin Pook

Carmen Doran

Dr Jim Polston

Leila De Koster

Bruce Wallace

The Leadership Team at Helius Therapeutics is responsible for guiding the company's strategic vision, ensuring operational excellence, and fostering innovation in the field of medicinal cannabis. Comprising executives with expertise in quality control, operations, science, and commercialization, the team collaborates to drive research and development initiatives, uphold regulatory compliance, and expand market presence, ultimately setting industry standards for effective and accessible medicinal cannabis products.

Leadership Team

Cultivation and Production Team

Finance and Operations

Leadership Team

About

Team members

Other teams at Helius Therapeutics

Cultivation and Production Team

Finance and Operations